Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jyoti Rana

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Journal of Thrombosis and Haemostasis : JTH|March 8, 2025
An engineered Treg selective immunocytokine induces sustained immune modulation in a preclinical model of hemophilia AJyoti Rana, Derek VanDyke, Maite Muñoz-Melero, et al.
Virus Research|September 7, 2012
Mapping interactions of Chikungunya virus nonstructural proteinsR Sreejith, Jyoti Rana, Namrata Dudha, et al.
Human Gene Therapy|March 23, 2023
Characterization of a Bioengineered AAV3B Capsid Variant with Enhanced Hepatocyte Tropism and Immune EvasionJyoti Rana, Damien Marsic, Chenhui Zou, et al.
The Journal of Clinical Investigation|March 2, 2021
B cell-activating factor modulates the factor VIII immune response in hemophilia ABhavya S Doshi, Jyoti Rana, Giancarlo Castaman, et al.
Cellular Immunology|February 6, 2023
Suppression of anti-drug antibody formation against coagulation factor VIII by oral delivery of anti-CD3 monoclonal antibody in hemophilia A miceThais B Bertolini, Roland W Herzog, Sandeep R P Kumar, et al.
Molecular Therapy. Methods & Clinical Development|March 5, 2024
B cell focused transient immune suppression protocol for efficient AAV readministration to the liverJyoti Rana, Roland W Herzog, Maite Muñoz-Melero, et al.
Frontiers in Immunology|November 13, 2023
Distinct functions and transcriptional signatures in orally induced regulatory T cell populationsMoanaro Biswas, Kaman So, Thais B Bertolini, et al.
Frontiers in Immunology|July 16, 2025
CXCR5 engineered human and murine Tregs for targeted suppression in secondary and tertiary lymphoid organsMatteo Doglio, Jyoti Rana, Adriana Stucchi, et al.
Molecular Therapy. Methods & Clinical Development|November 4, 2020
Engineering and <i>In Vitro</i> Selection of a Novel AAV3B Variant with High Hepatocyte Tropism and Reduced SeroreactivityMoanaro Biswas, Damien Marsic, Ning Li, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2026
Soluble LAG-3 Identifies a Dynamic Early T Cell Activation Window in self-reactivity, Type 1 Diabetes, and Broader Immune ResponsesSaptarshi Roy, Megan L Proffer, Farooq Syed, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Journal of Thrombosis and Haemostasis : JTH|March 8, 2025
An engineered Treg selective immunocytokine induces sustained immune modulation in a preclinical model of hemophilia AJyoti Rana, Derek VanDyke, Maite Muñoz-Melero, et al.
Virus Research|September 7, 2012
Mapping interactions of Chikungunya virus nonstructural proteinsR Sreejith, Jyoti Rana, Namrata Dudha, et al.
Human Gene Therapy|March 23, 2023
Characterization of a Bioengineered AAV3B Capsid Variant with Enhanced Hepatocyte Tropism and Immune EvasionJyoti Rana, Damien Marsic, Chenhui Zou, et al.
The Journal of Clinical Investigation|March 2, 2021
B cell-activating factor modulates the factor VIII immune response in hemophilia ABhavya S Doshi, Jyoti Rana, Giancarlo Castaman, et al.
Cellular Immunology|February 6, 2023
Suppression of anti-drug antibody formation against coagulation factor VIII by oral delivery of anti-CD3 monoclonal antibody in hemophilia A miceThais B Bertolini, Roland W Herzog, Sandeep R P Kumar, et al.
Molecular Therapy. Methods & Clinical Development|March 5, 2024
B cell focused transient immune suppression protocol for efficient AAV readministration to the liverJyoti Rana, Roland W Herzog, Maite Muñoz-Melero, et al.
Frontiers in Immunology|November 13, 2023
Distinct functions and transcriptional signatures in orally induced regulatory T cell populationsMoanaro Biswas, Kaman So, Thais B Bertolini, et al.
Frontiers in Immunology|July 16, 2025
CXCR5 engineered human and murine Tregs for targeted suppression in secondary and tertiary lymphoid organsMatteo Doglio, Jyoti Rana, Adriana Stucchi, et al.
Molecular Therapy. Methods & Clinical Development|November 4, 2020
Engineering and <i>In Vitro</i> Selection of a Novel AAV3B Variant with High Hepatocyte Tropism and Reduced SeroreactivityMoanaro Biswas, Damien Marsic, Ning Li, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2026
Soluble LAG-3 Identifies a Dynamic Early T Cell Activation Window in self-reactivity, Type 1 Diabetes, and Broader Immune ResponsesSaptarshi Roy, Megan L Proffer, Farooq Syed, et al.
Pageof 4